SGLT2 Inhibitors in Diabetes: Benefits, Side Effects and Sick-Day Safety | Dr. Moxit Shah
SGLT2 inhibitors are an important class of medicines used in type 2 diabetes. Their role extends beyond glucose lowering: in appropriate patients, they can reduce the risk of heart failure and slow progression of chronic kidney disease.
How Do SGLT2 Inhibitors Work?
These medicines reduce glucose and sodium reabsorption in the kidney, increasing urinary glucose excretion. They also produce effects on blood pressure, intraglomerular pressure and fluid balance.
Who May Benefit?
ADA 2026 recommends SGLT2 inhibitors with demonstrated benefit for appropriate people with type 2 diabetes and chronic kidney disease, heart failure, or established or high cardiovascular risk. The choice depends on kidney function, comorbidities, adverse-effect risk and individual preferences.
Important Side Effects
- Genital fungal infections can occur.
- Volume depletion and low blood pressure may occur, particularly during illness or poor fluid intake.
- Rarely, diabetic ketoacidosis can occur, sometimes with only modest glucose elevation.
Sick-Day and Surgery Safety
People taking an SGLT2 inhibitor should understand when temporary interruption may be necessary. ADA 2026 advises discontinuation before scheduled surgery and emphasizes sick-day planning and awareness of ketoacidosis symptoms. Prolonged fasting, critical illness and insulin deficiency increase risk.
Do Not Start or Stop It Without Medical Review
SGLT2 inhibitors are not suitable for every person with diabetes. Before starting treatment, clinicians consider kidney function, hydration, blood pressure, concurrent medicines, history of ketoacidosis and the person’s cardiovascular and kidney profile.
What Should Patients Remember?
- Maintain adequate hydration according to your medical needs.
- Know the warning symptoms of diabetic ketoacidosis, including nausea, vomiting, abdominal discomfort, unusual tiredness or difficulty breathing.
- Discuss planned surgery, prolonged fasting or significant acute illness with your treating team.
- Genital or urinary symptoms should be discussed promptly if they occur.
- Do not restart a temporarily stopped medicine until your treating clinician has advised when it is appropriate.
How SGLT2 Medicines Fit Into Diabetes Care
The decision to use an SGLT2 inhibitor depends on the person’s overall treatment goals. For some people the kidney or heart benefits may be particularly relevant; for others, another treatment may better match their clinical needs. Diabetes treatment should therefore be individualized rather than based on HbA1c alone.
The right medicine depends on kidney function, blood pressure, hydration status, concurrent medicines and the person’s cardiovascular and kidney profile. SGLT2 inhibitors are not simply “sugar tablets”; their benefits and risks need individualized assessment.
Related Diabetes Care
Good diabetes treatment also includes nutrition, physical activity, Weight Loss and complication screening. Explore our Diabetes Specialist in Ahmedabad page, Complete Diabetes guide, Diabetes Medicines guide and Diabetes and Kidney Protection guide.
References
- ADA Standards of Care in Diabetes—2026: Pharmacologic Approaches to Glycemic Treatment.
- ADA Standards of Care in Diabetes—2026: Cardiovascular Disease and Risk Management.
Dr. Moxit Shah, DM Endocrinology
Vishuddha Diabetes, Thyroid, Weight Loss Clinic, Ahmedabad
Phone: +91 99799 92797
